Publications by authors named "Noriyasu Chika"

Article Synopsis
  • This study evaluated the effectiveness of comprehensive genomic profiling (CGP) in metastatic colorectal cancer (mCRC) using real-world data from Saitama Medical Center between 2020 and 2023.
  • Out of 43 enrolled patients, only 14% received CGP-based therapy, with a median overall survival of 9.7 months for those patients.
  • The results indicate that CGP may have potential in guiding treatment for mCRC, as one patient showed a significant response to pembrolizumab after CGP revealed a high tumor mutational burden despite initial classifications.
View Article and Find Full Text PDF
Article Synopsis
  • A new model for predicting germline pathogenic variants (GPVs) of the APC gene in patients with adenomatous polyposis is being developed to aid in clinical diagnosis and management, especially when genetic testing is unavailable.
  • In a study of 162 patients, 55.6% were found to have GPVs of the APC gene, with key predictors identified, including age under 40, 100 or more polyps, fundic gland polyposis, and a family history of colorectal polyposis.
  • The predictive model demonstrated high accuracy (area under the curve of 0.91) and aims to assist both patients and healthcare providers in deciding on the necessity of genetic testing.
View Article and Find Full Text PDF
Article Synopsis
  • The study classifies deficient DNA mismatch repair (dMMR) solid tumors into three categories: MLH1-hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors, with varying incidences and unclear pathogenic genes for LLS.
  • Researchers analyzed 3,609 tumors from nine different organs, assessing the loss of MMR proteins and performing both methylation and genetic tests, finding that 5.9% of these tumors were dMMR.
  • Results indicated that varying tumor types show different incidences of dMMR, with several somatic MMR gene variants identified in LLS tumors, highlighting the need for further studies on LLS genetics for better patient counseling
View Article and Find Full Text PDF

Purpose: This retrospective study was performed to investigate the recent trend of occurrence of cancer of the remnant colorectal segment(RCRS)after ileal-pouch anal anastomosis(IPAA)/ileorectal anastomosis(IRA)and to consider the optimal surveillance methods in patients with familial adenomatous polyposis(FAP)undergoing(procto)colectomy.

Patients And Methods: The subject was a total of patients with FAP undergoing IPAA or IRA between 2005 and 2022. Clinicopathological data were extracted from medical charts and analyzed.

View Article and Find Full Text PDF

Cronkhite-Canada syndrome(CCS)is a rare non-inherited disease characterized by gastrointestinal polyposis and ectodermal abnormalities. We report a rare case of CCS associated with gastric cancer and gastric outlet obstruction with a review of the literature. A 75-year-old man was admitted because of frequent vomiting and hypoproteinemia.

View Article and Find Full Text PDF

Immune checkpoint inhibitors(ICIs)are widely used for the treatment of unresectable gastric cancer. We treated approximately 70 patients with ICIs. ICI treatment with pembrolizumab was administered for MSI-high cases and nivolumab for MSS cases in the second- or third-line chemotherapy.

View Article and Find Full Text PDF

A 47-year-old woman diagnosed with transverse colon cancer with liver, peritoneal, and lymph node metastases was admitted. Modified FOLFOX6(mFOLFOX6)regimen was given as a first line chemotherapy and was followed by pembrolizumab after 1 cycle of the mFOLFOX6, because microsatellite instability(MSI)test of the tumor showed high-frequency MSI. Because of the transverse colon obstruction after 2 cycles of pembrolizumab, she underwent right hemicolectomy.

View Article and Find Full Text PDF
Article Synopsis
  • The study addresses the challenges of managing colorectal polyp burden in patients with familial adenomatous polyposis (FAP) and explores the potential of tailoring management strategies based on genetic types (genotypes).
  • Using data from a Japanese multicenter study, the research evaluates the risk of colorectal cancer (CRC) associated with two different genotype groups: Genotype-1 and Genotype-2.
  • Findings indicate patients with Genotype-1 have a significantly lower risk of advanced CRC compared to Genotype-2, suggesting the need for genotype-specific approaches in clinical management, which require further validation through future studies.
View Article and Find Full Text PDF

The patient is a 73-year-old man who was diagnosed with perianal Paget's disease by skin biopsy. Biopsy from the dentate line did not show any tumor cells. The patient was considered to undergo sphincter-preserving local resection and subsequently underwent the procedure.

View Article and Find Full Text PDF

An 81-year-old female visited a local hospital with complaints of anal pain. A tumor was found on the right side of her anus, and the histopathological diagnosis was a non-epithelial malignant tumor. Therefore, the patient was referred to our hospital.

View Article and Find Full Text PDF

A 55-year-old woman had been admitted to a hospital with abdominal bloating. Retroperitoneal liposarcoma was suspected and diagnosed as not resectable. She was then referred to our hospital with dyspnea and difficulties with movement due to the huge mass.

View Article and Find Full Text PDF
Article Synopsis
  • * In the first case, a 22-year-old woman with LFS developed upper rectal cancer and underwent extensive surgery, but her condition deteriorated after 32 months despite additional treatments.
  • * The second case involves her older sister, who had a brain tumor linked to LFS; although it reoccurred after 46 months, she successfully underwent surgery and radiation, showing no signs of worsening since the treatment.
View Article and Find Full Text PDF

Background: This study aimed to assess current trends in morbidity and mortality among patients with familial adenomatous polyposis (FAP). These data can be used for optimal surveillance and management of such patients.

Methods: Data (November 2001 and April 2020) of genetically confirmed patients with FAP (n = 87) and their first-degree relatives with FAP phenotype (n = 20) were extracted from the Saitama Medical Center database.

View Article and Find Full Text PDF

Introduction: The prognosis for metastatic colorectal cancer patients (mCRC) with the BRAF mutation is poor. BRAF mutation frequency is reportedly low among Asians; however, the frequency of the BRAF mutation in right-side colon cancer may not be low, even among Asians. In addition, spatial heterogeneity of BRAF mutations also exists, as for RAS mutations.

View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed the clinicopathological and survival data of 8 patients with unresectable gastric cancer who underwent conversion surgery after second-line chemotherapy from 2013 to 2020.
  • The patients included 7 males and 1 female, with a median age of 69, and all achieved complete removal of cancer (R0 resection).
  • Results indicated that undergoing conversion surgery after chemotherapy significantly improved median survival times compared to those who did not have surgery, suggesting it may enhance survival for patients with unresectable gastric cancer.
View Article and Find Full Text PDF

We report a rare carcinoma of the permanent ileostomy site developing 20 years or more after total proctocolectomy (TPC)in a 65-year-old woman with familial adenomatous polyposis(FAP). She underwent TPC for rectal cancer associated with FAP in her 40th at other institution. She also underwent pancreas-sparing total duodenectomy for duodenal mucosal cancer associated with severe duodenal polyposis at 59 years at our institution.

View Article and Find Full Text PDF

We investigated changes in estimated glomerular filtration rate(eGFR)in 11 colorectal cancer patients(6 familial adenomatous polyposis, 5 ulcerative colitis)who underwent restorative proctocolectomy with ileal pouch-anal anastomosis(IPAA) and diverting ileostomy(DI), the tolerability and adverse events of adjuvant chemotherapy(ACT)in 4 cases. After IPAA, eGFR decreased significantly(p=0.02)and did not return to the preoperative level even after stoma closure(p<0.

View Article and Find Full Text PDF

We herein report 3 cases of advanced gastric cancer with multiple liver metastases who was successfully treated with systemic chemotherapy and underwent conversion surgery with liver resection. There were 2 males and 1 female patients with a range 68 to 74 years of age. Two patients received S-1 plus oxaliplatin therapy and 1 received S-1 plus cisplatin therapy.

View Article and Find Full Text PDF

Esophageal neuroendocrine carcinoma is extremely rare, and its treatment strategy has not been established. We report 2 cases esophageal neuroendocrine carcinoma. Case 1: A 74-year-old man was diagnosed as having esophageal neuroendocrine carcinoma(clinical T3N4M0, Stage Ⅳa).

View Article and Find Full Text PDF

The efficacy of pembrolizumab has been demonstrated for all solid tumors showing high frequency microsatellite instability- high(MSI-High). It is a possible treatment option even in cases which do not respond to other forms of chemotherapy. We report a case of a 69-year-old man with MSI-High recurrent colorectal cancer with complete response(CR)after pembrolizumab therapy.

View Article and Find Full Text PDF

The proband was a 77-year-old man who had been admitted to a local hospital for fecal occult blood. He was diagnosed with descending colon carcinoma, T4a, N1, M0, Stage Ⅲb, and rectal adenoma. He had undergone surgeries for rectal cancer at 52 years of age and cecum colon cancer at 57 years of age.

View Article and Find Full Text PDF

The proband was a 49-year-old woman who had undergone total colectomy, ileorectostomy, and bilateral ovariectomy for the treatment of cecal(T3N0)and sigmoid colon(T4a, N2b, M1c2[Ova], Stage Ⅳc)cancers. Pathological findings revealed 6 adenomas and 2 adenocarcinoma-in-adenomas in the right colon, other than advanced colon cancers. She had a family history of colorectal cancer meeting the Amsterdam Criteria I, but none of her relatives had definite polyposis.

View Article and Find Full Text PDF

Objectives: To investigate the prevalence and molecular characteristics of defective DNA mismatch repair (dMMR) in small-bowel carcinoma (SBC) in a Japanese-hospital population.

Methods: Immunohistochemistry was performed to evaluate the expression of MMR proteins (MLH1, MSH2, MSH6, and PMS2) in formalin-fixed paraffin-embedded sections prepared from surgically resected primary SBCs from 30 patients during March 2002 to March 2017. Genetic testing for Lynch syndrome was performed in patients who demonstrated MMR protein loss.

View Article and Find Full Text PDF

Background: The prevalence and molecular characteristics of defective DNA mismatch repair endometrial cancers in the Japanese population have been underexplored. Data supporting clinical management of patients with Lynch-like syndrome and germline variant of uncertain significance of mismatch repair genes are still lacking.

Methods: Immunohistochemistry of mismatch repair proteins (MLH1, MSH2, MSH6 and PMS2) was performed on formalin-fixed paraffin-embedded sections prepared from resected primary endometrial cancers in 395 women with a median age of 59 years.

View Article and Find Full Text PDF

Background/aim: Identifying patients with DNA mismatch repair-deficient (dMMR) colorectal cancer (CRC) is vital to improve treatment and identify patients with Lynch syndrome (LS). We developed a prediction model for dMMR CRC using clinicopathologic features.

Patients And Methods: We reviewed the medical records of 1,147 patients who underwent resection of stage I-IV CRC in whom universal screening for LS using immunohistochemistry for MMR proteins had performed.

View Article and Find Full Text PDF